Eplerenone v placebo for myocardial infarction at mean 16 months‡
| Outcomes | Eplerenone | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| ‡CV = cardiovascular. Other abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| Death from any cause | 14% | 17% | 15% (4 to 25) | 44 (25 to 174) |
| Death from CV causes or CV event hospital admission | 27% | 30% | 13% (5 to 21) | 31 (19 to 88) |
| Death from any cause or any hospital admission | 52% | 55% | 8% (2 to 14) | 33 (19 to 147) |
| Death from CV causes | 12% | 15% | 17% (6 to 28) | 44 (26 to 148) |